SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001016169-07-000041
Filing Date
2007-07-02
Accepted
2007-07-02 15:31:27
Documents
6
Period of Report
2007-06-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 from8k.htm 8-K 31157
2 comstkwrntpurchagre.htm EX-4.1 185135
3 investorrights.htm EX-4.2 116783
4 cmnstkwarrant.htm EX-4.3 97266
5 pressrelease.htm EX-99.1 10499
6 GRAPHIC img1.jpg GRAPHIC 3740
  Complete submission text file 0001016169-07-000041.txt   447992
Mailing Address 250 PHILLIPS BLVD SUITE 290 EWING NJ 08618
Business Address 250 PHILLIPS BLVD SUITE 290 EWING NJ 08618 609-359-3020
ANTARES PHARMA INC (Filer) CIK: 0001016169 (see all company filings)

IRS No.: 411350192 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32302 | Film No.: 07954971
SIC: 3841 Surgical & Medical Instruments & Apparatus